Evidence map›Paper›PMID 41594015›Full record

ArticleEntropy (Basel, Switzerland)2026

Entropy-Augmented Forecasting and Portfolio Construction at the Industry-Group Level: A Causal Machine-Learning Approach Using Gradient-Boosted Decision Trees.

Gil Cohen, Avishay Aiche, Ron Eichel

Abstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gil CohenManagement Department, Western Galilee College, Acre 2412101, Israel.ORCID 0000-0002-1173-0338
Avishay AicheManagement Department, Western Galilee College, Acre 2412101, Israel.
Ron EichelManagement Department, Western Galilee College, Acre 2412101, Israel.ORCID 0000-0002-4951-9781

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper examines whether information-theoretic complexity measures enhance industry-group return forecasting and portfolio construction within a machine-learning framework. Using daily data for 25 U.S. GICS industry groups spanning more than three decades, we augment gradient-boosted decision tree models with Shannon entropy and fuzzy entropy computed from recent return dynamics. Models are estimated at weekly, monthly, and quarterly horizons using a strictly causal rolling-window design and translated into two economically interpretable allocation rules, a maximum-profit strategy and a minimum-risk strategy. Results show that the top performing strategy, the weekly maximum-profit model augmented with Shannon entropy, achieves an accumulated return exceeding 30,000%, substantially outperforming both the baseline model and the fuzzy-entropy variant. On monthly and quarterly horizons, entropy and fuzzy entropy generate smaller but robust improvements by maintaining lower volatility and better downside protection. Industry allocations display stable and economically interpretable patterns, profit-oriented strategies concentrate primarily in cyclical and growth-sensitive industries such as semiconductors, automobiles, technology hardware, banks, and energy, while minimum-risk strategies consistently favor defensive industries including utilities, food, beverage and tobacco, real estate, and consumer staples. Overall, the results demonstrate that entropy-based complexity measures improve both economic performance and interpretability, yielding industry-rotation strategies that are simultaneously more profitable, more stable, and more transparent.

Indexed as

gradient boostingindustrymachine learningportfolio

Identifiers

PMID41594015
PMCPMC12840230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.